Ozempic and Mounjaro are similar in many ways, but there’s one key difference between the two. Learn how these blockbuster type 2 diabetes medications are changing the landscape of diabetes management, and find out why they aren’t yet approved for use in type 1.
read more →
2025 is shaping up to be a blockbuster year in diabetes care! From smart MDI systems to medications that pull triple duty, the future is looking smarter—and less invasive.
Here are several key advancements we expect to see in 2025.
When diabetes lives with you day-to-day like a stage five clinger, it can be easy to feel like advancements in care aren’t happening at a fast enough pace. But we’re here to tell you, things are happening! Here’s a short list of some of the progress we saw in 2024, including new pumps, new CGMs, and exciting research studies with promising results.
read more →
Recent shortages of medications like Ozempic and Mounjaro have caused an influx of imitation drugs around the world. The FDA and World Health Organization have issued warnings about the safety risks of taking these counterfeit products because they can contain questionable ingredients that can cause series harm. Dr. Edelman explains how to know if the medication you’re taking is authentic and what to look out for in fake products.
read more →
The newer injectable type 2 diabetes medications can help lower glucose levels and A1c, improve overall diabetes management, and promote weight loss. However, it’s important to make nutritional adjustments while on these medications in order to have long-term success.
read more →
